Bowel Preparation Regimen for Colon Capsule Endoscopy Procedure
Colon Cancer, Inflammatory Bowel Diseases, Gastrointestinal Bleed
About this trial
This is an interventional diagnostic trial for Colon Cancer focused on measuring colon capsule endoscopy, panenteric capsule endoscopy, colon preparation
Eligibility Criteria
Inclusion Criteria: Subject referred for clinical colon/panenteric examination Subject received an explanation about the nature of the study and agreed to provide written informed consent Exclusion Criteria: Subject with dysphagia or any swallowing disorder Subject with a prior stomach, small bowel, or colonic resection Subject with severe renal insufficiency Subject with any allergy or other known contraindication to the medications used in the study Women who are either pregnant or nursing Subject suffers from life threatening conditions
Sites / Locations
- Skåne University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Experimental
Experimental
Standard preparation regimen
Optimized preparation regimen
Optimized preparation regimen with prucalopride
4 L polyethylene glycol as laxative 30 + 15 mL sodium phosphate as a booster
1 L polyethylene glycol + ascorbic acid as laxative and gastrografin and magnesiumoxid + sodium picosulfate as a booster
1 L polyethylene glycol + ascorbic acid as laxative and gastrografin and magnesiumoxid + sodium picosulfate as a booster + 2 mg of prucalopride